Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Want to know more?
Get in touch and send us an email.
Do you have any feedback or questions?
We are happy to hear from you.